London Trials

Offer

25-012 - Healthy Participants

A study investigating an experimental new medicine for treating macular degeneration. For healthy males or females aged 18 to 65. Admissions are on 24 August and 28 September 2026. The study involves 3 nights and up to 9 outpatient visits. Study payment: £3,250 to £8,500.

Offer

25-010 - Healthy Participants

A study investigating an experimental new medicine for treating various immune system diseases. For healthy males or females aged 18 to 65 with a BMI of 18 to 32 kg/m2 who are non-smokers. The study involves from 8 nights and 11 clinic visits. Start date: 26 August 2026. Study payment: up to £6,000.

Offer

25-501 - Healthy Participants for the FIBRE Liver Imaging Study

A study to investigate new methods of diagnosing and monitoring metabolic dysfunction-associated steatotic liver disease. For healthy males or females aged 23 to 75 with a BMI of 18.5 to 24.9 kg/m2. The study involves 2 screening visits and 2 one-day sessions. Study payment: from £2,700.

Offer

25-501 - Patients with MASLD

A study to investigate new methods of diagnosing and monitoring metabolic dysfunction-associated steatotic liver disease. For males or females aged 23 to 75 with a BMI from 25 kg/m2. The study involves 2 screening visits and 2 one-day sessions. Study payment: from £2,700.

Offer

25-011 - Healthy Participants

Healthy participants are needed for the study of an experimental new treatment for primary biliary cholangitis. Participants must be aged 18 to 65 with a BMI between 18 and 30 kg/m2. Smokers and vapers are allowed but cannot smoke or vape while in the ward. The study involves 3 nights’ residence on the wards and 5 outpatient visits if on placebo, plus 1 additional follow-up if receiving the study drug. Admissions are on 5 and 6 October 2026. Study payment: £3,000 to £4,000.

Offer

24-503 - People with CIPN

People with Chemotherapy Induced Peripheral Neuropathy are needed for a study of a potential new medicine, given as a gel, to treat the condition. Participants must be aged 18 to 80, have received chemotherapy treatment for cancer and be in remission, and have had CIPN for at least 3 months. The study involves up to 6 outpatient visits, including 3 optional skin biopsies, and 1 telephone follow-up. Study payment: up to £2,380.

Offer

25-008 - Healthy Volunteer Study

A study investigating an experimental new medicine for problems with thinking such as memory and concentration, linked to brain disorders like Alzheimer’s disease and schizophrenia. For healthy males or females aged 18 to 55 with a BMI of 18 to 30.9 kg/m2. The study involves 2 to 4 nights and at least 2 clinical visits. Start date: 3 September 2026. Study payment: £1,250 to £2,315.

Event

24-503 - People with CIPN

Thu, 20 Aug

A study of a potential new medicine, given as a gel, to treat chemotherapy induced peripheral neuropathy. For male or female participants aged 18 to 80 who have received chemotherapy treatment for cancer, are in remission and have had CIPN for at least 3 months. Participation involves up to 6 outpatient clinic visits, including 3 optional skin biopsies, and 1 telephone follow-up. Study payment is up to £2,380.

Event

25-501 - Patients with MASLD

Thu, 20 Aug

A study investigating new methods of diagnosing and monitoring metabolic dysfunction-associated steatotic liver disease. For male or female patients aged 23 to 75 with a BMI from 25 kg/m2. Participation involves 2 screening visits and 2 one-day sessions. Study payment is from £2,700.

Event

25-501 - Healthy participants for the FIBRE liver imaging study

Thu, 20 Aug

A study investigating new methods of diagnosing and monitoring metabolic dysfunction-associated steatotic liver disease. For healthy male or female participants aged 23 to 75 with a BMI of 18.5 to 24.9 kg/m2. Participation involves 2 screening visits and 2 one-day sessions. Study payment is from £2,700.

Event

25-010 - Healthy participants

Wed, 26 Aug

A study investigating an experimental new medicine for treating various immune system diseases. For healthy male or female participants aged 18 to 65 with a BMI of 18 to 32 kg/m2 who are non-smokers. Participation involves at least 8 nights and 11 clinic visits. Study payment is up to £6,000.

Event

25-008 - Healthy Volunteer Study

Thu, 3 Sept

A study investigating an experimental new medicine for problems with thinking such as memory and concentration, linked to brain disorders like Alzheimer's disease and schizophrenia. For healthy male or female participants aged 18 to 55 with a BMI of 18 to 30.9 kg/m2. Participation involves 2 to 4 nights and at least 2 clinical visits. Study payment is £1,250 to £2,315.

Event

25-012 - Healthy participants

Mon, 28 Sept

A study investigating an experimental new medicine for treating macular degeneration. For healthy male or female participants aged 18 to 65. Participation involves 3 nights and up to 9 outpatient visits. Admissions are on 24 August and 28 September 2026. Study payment is £3,250 to £8,500.

Event

25-011 - Healthy participants

Mon, 5 Oct

A study of an experimental new treatment for primary biliary cholangitis. For healthy male or female participants aged 18 to 65 with a BMI of 18 to 30 kg/m2. Smokers and vapers are allowed but cannot smoke or vape while in the ward. Participation involves 3 nights' residence on the wards and 5 outpatient visits if on placebo, plus 1 additional follow-up if receiving the study drug. Admissions are on 5 and 6 October 2026. Study payment is £3,000 to £4,000.